BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27449261)

  • 21. [TREATMENT OF AGE-RELATED ANDROGEN DEFICIENCY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA].
    Kaprin AD; Kostin AA; Vinogradov IV; Magamadov EL
    Urologiia; 2015; (1):79-80, 82. PubMed ID: 26094393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy and longevity.
    Comhaire F
    Andrologia; 2016 Feb; 48(1):65-8. PubMed ID: 25892327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer.
    Pastuszak AW; Khanna A; Badhiwala N; Morgentaler A; Hult M; Conners WP; Sarosdy MF; Yang C; Carrion R; Lipshultz LI; Khera M
    J Urol; 2015 Nov; 194(5):1271-6. PubMed ID: 26025500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sexual function rehabilitation of men with pituitary tumors].
    Rozhivanov RV; Kurbatov DG
    Urologiia; 2010; (4):48, 50-3. PubMed ID: 20973135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men.
    Rosen RC; Wu FC; Behre HM; Roehrborn CG; Schröder FH; Siami FS; Martha JF; Finn JD; Araujo AB
    Aging Male; 2013 Mar; 16(1):1-7. PubMed ID: 23373674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
    Brunton SA; Sadovsky R
    J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of erectile dysfunction after radical prostatectomy].
    Radnaev LG; Govorov AV; Pushkar' DIu
    Urologiia; 2010; (4):75-9. PubMed ID: 20967987
    [No Abstract]   [Full Text] [Related]  

  • 28. Testosterone therapy in men with untreated prostate cancer.
    Morgentaler A; Lipshultz LI; Bennett R; Sweeney M; Avila D; Khera M
    J Urol; 2011 Apr; 185(4):1256-60. PubMed ID: 21334649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy.
    Shoskes DA; Barazani Y; Fareed K; Sabanegh E
    Int Braz J Urol; 2015; 41(6):1167-71. PubMed ID: 26742976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?].
    Castillo OA; López-Fontana G; Vidal-Mora I; López Laur JD
    Medwave; 2015 Apr; 15(3):e6115. PubMed ID: 25919660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.
    van der Poel HG
    Eur Urol; 2009 Jul; 56(1):103-4. PubMed ID: 19282103
    [No Abstract]   [Full Text] [Related]  

  • 32. Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
    Saad F
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():52-9. PubMed ID: 23280867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
    Rhoden EL; Morgentaler A
    J Urol; 2003 Dec; 170(6 Pt 1):2348-51. PubMed ID: 14634413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Practical aspects of use of hormone replacement therapy with testosterone for age-related androgen deficiency in men].
    Korneev IA
    Urologiia; 2012; (5):122-4, 126-7. PubMed ID: 23342630
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.
    Kaplan AL; Hu JC
    Urology; 2013 Aug; 82(2):321-6. PubMed ID: 23706552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.
    Malkin CJ; Pugh PJ; West JN; van Beek EJ; Jones TH; Channer KS
    Eur Heart J; 2006 Jan; 27(1):57-64. PubMed ID: 16093267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone replacement therapy after primary treatment for prostate cancer.
    Agarwal PK; Oefelein MG
    J Urol; 2005 Feb; 173(2):533-6. PubMed ID: 15643240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone replacement therapy following radical prostatectomy.
    Khera M; Grober ED; Najari B; Colen JS; Mohamed O; Lamb DJ; Lipshultz LI
    J Sex Med; 2009 Apr; 6(4):1165-1170. PubMed ID: 19207277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
    Raynor MC; Carson CC; Pearson MD; Nix JW
    Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.